AbbVie Inc.ABBVNYSE
Loading
Revenue Growth Recovery in ProgressRecovering
Percentile Rank50
3Y CAGR+37.4%
5Y CAGR-25.6%
Studio
Year-over-Year Change

Year-over-year revenue growth rate

3Y CAGR
+37.4%/yr
vs -32.7%/yr prior
5Y CAGR
-25.6%/yr
Recent acceleration
Acceleration
+70.0pp
Accelerating
Percentile
P50
Within normal range
vs 5Y Ago
0.2x
Contraction
Streak
2 yr
Consecutive growthRecovering
PeriodValue
20258.57%
20243.71%
2023-6.44%
20223.30%
202122.69%
202037.69%
20191.57%
201816.08%
201710.06%
201612.16%